NGM Bio to Participate in the Cowen 42nd Annual Health Care Conference
February 28 2022 - 8:00AM
NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a
biotechnology company focused on discovering and developing
transformative therapeutics for patients, today announced that
David J. Woodhouse, Ph.D., Chief Executive Officer, will
participate in the Cowen 42nd Annual Health Care Conference as part
of the Novel Immuno-oncology (IO) Panel and will provide an
overview of the company and a business update focusing on NGM Bio’s
wholly-owned oncology portfolio on Monday, March 7, at 10:30 am ET.
A live webcast of the presentation will be available under the
Investors and Media section of NGM Bio’s website at
https://ir.ngmbio.com/events-presentations. A replay of each
presentation will be archived on NGM Bio’s site for 30 days
following the event.
About NGM Biopharmaceuticals, Inc.
NGM Bio is focused on discovering and developing novel,
life-changing medicines for people whose health and lives have been
disrupted by disease. The company’s biology-centric drug discovery
approach aims
to seamlessly integrate interrogation of complex
disease-associated biology and protein engineering expertise to
unlock proprietary insights that are leveraged to generate
promising product candidates and enable their rapid advancement
into proof-of-concept studies. As explorers on the frontier of
life-changing science, NGM Bio aspires to operate one of the most
productive research and development engines in the
biopharmaceutical industry. All therapeutic candidates in the NGM
Bio pipeline have been generated by its in-house discovery engine,
with a disease-agnostic mindset, always led by biology and
motivated by unmet patient need. Today, the company has seven
disclosed programs, including four in Phase 2 or 2b
studies, across three therapeutic areas:
cancer, retinal diseases and liver and
metabolic diseases. Visit us at www.ngmbio.com for more
information.
Investor Contact:Brian
Schoelkopfir@ngmbio.com |
Media Contact:media@ngmbio.com |
NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Sep 2024 to Oct 2024
NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Oct 2023 to Oct 2024